Eli Lilly stock pre-market at EUR 1060.00: minus 0.01 percent
Published on 10/08/2026 at 08:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
At 8:14 a.m. CEST on October 8, 2026, Eli Lilly and Co. stock was at EUR 1060.00 in pre-market trading at Lang & Schwarz, down 0.01 percent versus the prior close of EUR 1060.10 on October 7, 2026.
Pre-market price
Lang & Schwarz listed a bid of EUR 1058.00 and an ask of EUR 1062.00. The pre-market price was EUR 1060.00, a decrease of 0.01 percent from the prior close. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Eli Lilly stock.
Previous trading session
The reference price at Lang & Schwarz was EUR 1060.10 on October 7, 2026. The current bid-ask spread indicated EUR 4.00 between the bid and ask prices before the Xetra session.
Dermatology data scheduled for presentation
In a release dated October 5, 2026, Eli Lilly and Company said it would present 21 posters at the Fall Clinical Dermatology Conference in Las Vegas from October 8 through October 11. The company said the presentations covered EBGLYSS, Taltz, Zepbound and Olumiant. Thirteen presentations concerned EBGLYSS, including data on disease control, maintenance dosing and pediatric patients. Six presentations addressed the concomitant use of Taltz and Zepbound in psoriasis and obesity or overweight. The release also described long-term outcomes for Olumiant in pediatric patients with severe alopecia areata.
